Virologic failures on initial boosted-pi regimen infrequently possess low-level variants with major pi resistance mutations by ultra-deep sequencing

HIGHLIGHTS

• who: Virologic Failures on Initial and colleagues from the Research and Development, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America, Yale University School of Medicine and Veterans Affairs Health have published the article: Virologic Failures on Initial Boosted-PI Regimen Infrequently Possess Low-Level Variants with Major PI Resistance Mutations by Ultra-Deep Sequencing, in the Journal: (JOURNAL) of February/15,/2012
• what: The aim of this study was to determine if patients with virologic failure on an initial PI/r-based regimen without resistance by standard genotyping possess low-level drug resistant variants . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.